The Changing Landscape of Hepatitis C Testing and Therapy
The discovery, diagnosis, and treatment of the hepatitis C virus (HCV) rank as one of modern medicine’s great accomplishments. At each stage of the HCV revolution, laboratory testing has been key to foundational research, identification of chronically infected patients, and rational guidance of evolving therapies. Recent initiatives for comprehensive screening and the availability of new well-tolerated, highly effective therapies have galvanized the public’s attention as never before.
This video lecture will review the evolving role of laboratory testing in the diagnosis and management of chronic HCV infection, focusing on current guidelines and test resources. It will also address expected public health outcomes and issues in this era of the HCV cure.
Originally presented on September 30, 2015 in Salt Lake City, Utah.
David R. Hillyard, MD
Medical Director, Molecular Infectious Diseases, ARUP Laboratories
Professor of Pathology, University of Utah School of Medicine
Dr. Hillyard is a professor of pathology at the University of Utah School of Medicine. Dr. Hillyard received his MD from the Columbia University College of Physicians and Surgeons. His training was in anatomic and clinical pathology, with fellowships in medical microbiology and microbial genetics.
After this presentation, participants will be able to:
- Review guidelines for universal HCV screening and current testing challenges.
- Discuss rapidly evolving new options for HCV treatment and their impact on laboratories.
- Evaluate guidelines and best practices for assessing and monitoring patients with chronic HCV.
University of Utah School of Medicine, Department of Pathology, and ARUP Laboratories